The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects

Author(s):
Donze, S.H.; Meijer, C.R.; Kant, S.G.; Zandwijken, G.R.J.; Hout, A.H. van der; Spaendonk, R.M.L. van; Ouweland, A.M.W. van den; Wit, J.M.; Losekoot, M.; Oostdijk, W. (0000-0003-0180-2470)
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-11-30
Language
English
Is part of
European Journal of Endocrinology (2015), Vol. 173, no. 5, p. 611-621
hdl
1887/107499
doi
10.1530/EJE-15-0451